Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bioasis Technologies Inc. V.BTI

Alternate Symbol(s):  BIOAF

Bioasis Technologies Inc. is a multi-asset rare and orphan disease biopharmaceutical company developing clinical stage programs based on epidermal growth factors and the xB3™ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need. The in-house development programs are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.


TSXV:BTI - Post by User

Comment by narmacon Nov 09, 2021 4:15pm
118 Views
Post# 34106678

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Aposense updating website

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Aposense updating websiteHummmmm,,,KBC,,,,,,Sam is awesome!!!,,,,,I have his podcasts on line on multiple subjects,,,,is it working for you?,,,I also have other personalities on podcast as well,,,,why do you think I am suffering??...these biotechs tend to suck the energy out of their investors in my experience ...my latest comment/s here was in regards to a business model in the biotech world,,,,,perhaps suited towards companies with multiple horses in the bio race while having MT pockets...,,my point is an opinion,,,,,failure to lanuch progress activites to meet milestones should be pointed out as managment is expected to keep their shareholders up to speed with accurate communications. Its what any investor would expect from their company.  
<< Previous
Bullboard Posts
Next >>